Mohamed Atta

Professor

1992 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Mohamed Atta is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 17 Similar Profiles
HIV Medicine & Life Sciences
AIDS-Associated Nephropathy Medicine & Life Sciences
Kidney Medicine & Life Sciences
Kidney Diseases Medicine & Life Sciences
HIV Infections Medicine & Life Sciences
Biopsy Medicine & Life Sciences
HIV-1 Medicine & Life Sciences
Chronic Kidney Failure Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1992 2019

Clinical Pharmacology in HIV Therapy

Atta, M., De Seigneux, S. & Lucas, G. M., Mar 7 2019, In : Clinical journal of the American Society of Nephrology : CJASN. 14, 3, p. 435-444 10 p.

Research output: Contribution to journalArticle

Open Access
Clinical Pharmacology
HIV
HIV-1
Anti-Retroviral Agents
Morbidity
Open Access
Cystatin C
cystatins
glomerular filtration rate
T-cells
Iohexol

Pegunigalsidase alfa, a novel PEGylated enzyme replacement therapy for Fabry disease, provides sustained plasma concentrations and favorable pharmacodynamics: A 1-year Phase 1/2 clinical trial

Schiffmann, R., Goker-Alpan, O., Holida, M., Giraldo, P., Barisoni, L., Colvin, R. B., Jennette, C. J., Maegawa, G., Boyadjiev, S. A., Gonzalez, D., Nicholls, K., Tuffaha, A., Atta, M., Rup, B., Charney, M. R., Paz, A., Szlaifer, M., Alon, S., Brill-Almon, E., Chertkoff, R. & 1 others, Hughes, D., Jan 1 2019, In : Journal of Inherited Metabolic Disease.

Research output: Contribution to journalArticle

Open Access
Enzyme Replacement Therapy
Fabry Disease
Clinical Trials, Phase I
Kidney
Half-Life

Allogeneic mesenchymal stem cells for treatment of AKI after cardiac surgery

Swaminathan, M., Stafford-Smith, M., Chertow, G. M., Warnock, D. G., Paragamian, V., Brenner, R. M., Lellouche, F., Fox-Robichaud, A., Atta, M., Melby, S., Mehta, R. L., Wald, R., Verma, S., Mazer, C. D., Lombard, F. W., Schroder, J., Kurtzberg, J., Bisnar, T., Conte, J., Dodd-o, J. M. & 37 others, Rabb, H., Katz, N., Shah, A., Huyette-Arrizza, E., Bellot, C., Kramer, R., Tolson, B., Solomon, R., Brooks, C., Mora-Mangano, C., Wong, J., Kashani, K., Naka, Y., Umanath, K., Yee, J., Kilic, A., Lecker, S., Frendl, G., MacKensen, B., Simon, M., Dagenais, F., Ferland, M. C., Bouchard, P. A., Whitlock, R., Ainsworth, C., McDonald, E., Curley, G., Yagnik, S., Crescini, C., Ferland, A., Maier, K., Denault, A., Ly, H., Bainbridge, D., Bentall, T., Légaré, J. F. & Grocott, H., Jan 1 2018, In : Journal of the American Society of Nephrology. 29, 1, p. 260-267 8 p.

Research output: Contribution to journalArticle

Mesenchymal Stromal Cells
Thoracic Surgery
Placebos
Recovery of Function
Kidney

Association of HIV Suppression With Kidney Disease Progression Among HIV-Positive African Americans With Biopsy-Proven Classic FSGS

McMahon, B. A., Hanouneh, M., Chedid, A., Fine, D. M., Chen, T., Foy, M., Lucas, G. M., Estrella, M. M. & Atta, M., Dec 15 2018, In : Journal of acquired immune deficiency syndromes (1999). 79, 5, p. 639-643 5 p.

Research output: Contribution to journalArticle

Focal Segmental Glomerulosclerosis
Kidney Diseases
African Americans
Disease Progression
HIV